Short Interest in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Declines By 40.0%

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 900 shares, a drop of 40.0% from the December 31st total of 1,500 shares. Based on an average daily volume of 2,300 shares, the short-interest ratio is presently 0.4 days.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

Shares of First Trust Nasdaq Pharmaceuticals ETF stock traded down $0.13 during trading on Friday, reaching $27.74. 3,160 shares of the company’s stock were exchanged, compared to its average volume of 2,518. First Trust Nasdaq Pharmaceuticals ETF has a 1-year low of $25.73 and a 1-year high of $29.72. The company has a market cap of $15.26 million, a P/E ratio of 15.98 and a beta of 0.70. The firm’s 50-day moving average price is $27.46 and its 200 day moving average price is $28.22.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th were paid a dividend of $0.1304 per share. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13. The ex-dividend date was Friday, December 13th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.